CP-945,598

DRUG9 trials

Sponsors

Pfizer, National Institute on Aging (NIA)

Conditions

Healthy VolunteersHepatic InsufficiencyObesity

Phase 1

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

CompletedNCT00472836

Start: 2007-06-30End: 2008-10-31Updated: 2009-08-13

Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

CompletedNCT00644839

Start: 2008-04-30End: 2008-07-31Updated: 2009-08-13

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

CompletedNCT00645021

PfizerHepatic Insufficiency, Obesity

Start: 2008-04-30End: 2008-10-31Updated: 2009-08-27

Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety

CompletedNCT00645216

Start: 2007-06-30End: 2007-10-31Target: 28Updated: 2009-08-10

Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics

CompletedNCT00645463

Start: 2007-03-31End: 2007-06-30Updated: 2009-09-17

The Role of Endocannabinoids in Insulin Production and Action

CompletedNCT01517100

National Institute on Aging (NIA)Healthy Volunteers

Start: 2012-01-05End: 2014-10-06Updated: 2026-03-31

Phase 2

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

CompletedNCT00134199

Start: 2005-03-31End: 2005-11-30Updated: 2009-08-12

Phase 3

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

TerminatedNCT00391196

Start: 2006-11-30End: 2009-01-31Updated: 2012-11-07

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

TerminatedNCT00483171

Start: 2008-01-31End: 2009-01-31Updated: 2012-11-07